Abstract
Abstract
Background
Burn-related injuries are a major global health issue, causing 180,000 deaths per year. Early debridement of necrotic tissue in association with a split-thickness skin graft is usually administered for some of the 2nd- and 3rd-degree injuries. However, this approach can be complicated by factors such as a lack of proper donor sites. Artificial skin substitutes have attracted much attention for burn-related injuries. Keratinocyte sheets are one of the skin substitutes that their safety and efficacy have been reported by previous studies.
Methods
Two consecutive clinical trials were designed, one of them is phase I, a non-randomized, open-label trial with 5 patients, and phase II is a randomized and open-label trial with 35 patients. A total number of 40 patients diagnosed with 2nd-degree burn injury will receive allogenic keratinocyte sheet transplantation. The safety and efficacy of allogeneic skin graft with autograft skin transplantation and conventional treatments, including Vaseline dressing and topical antibiotic, will be compared in different wounds of a single patient in phase II. After the transplantation, patients will be followed up on days 3, 7, 10, 14, 21, and 28. In the 3rd and 6th months after the transplantation scar, a wound closure assessment will be conducted based on the Vancouver Scar Scale and the Patient and Observer Scar Assessment Scale.
Discussion
This study will explain the design and rationale of a cellular-based skin substitute for the first time in Iran. In addition, this work proposes this product being registered as an off-the-shelf product for burn wound management in the country.
Trial registration
Iranian Registry of Clinical Trials (IRCT) IRCT20080728001031N31, 2022-04-23 for phase I and IRCT20080728001031N36, 2024-03-15 for phase II.
Funder
Royan Institute for Stem Cell Biology and Technology
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Price K, Lee KC, Woolley KE, Falk H, Peck M, Lilford R, et al. Burn injury prevention in low- and middle-income countries: scoping systematic review. Burns Trauma. 2021;9:tkab037.
2. Jeschke MG, van Baar ME, Choudhry MA, Chung KK, Gibran NS, Logsetty S. Burn injury Nat Rev Dis Primers. 2020;6(1):11.
3. Lukomskyj AO, Rao N, Yan L, Pye JS, Li H, Wang B, et al. Stem cell-based tissue engineering for the treatment of burn wounds: a systematic review of preclinical studies. Stem Cell Rev Rep. 2022;18(6):1926–55.
4. Saavedra PAE, De Oliveira Leal JV, Areda CA, Galato D. The costs of burn victim hospital care around the world: a systematic review. Iran J Public Health. 2021;50(5):866–78.
5. Hosseinpour H, Kamran H, Zahmatkesh Meimandi F, Shahrbaf MA, Shekouhi R, Salimi M, et al. A retrospective epidemiological study of outpatient burn care during 2010–2019 in Iran. Burns Open. 2022;6(3):129–35.